358 related articles for article (PubMed ID: 7572311)
1. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
2. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy.
Uehara R; Suzuki Y; Ichikawa Y
J Rheumatol; 2001 Feb; 28(2):251-6. PubMed ID: 11246658
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells.
Kassem M; Mosekilde L; Eriksen EF
J Bone Miner Res; 1993 Dec; 8(12):1453-8. PubMed ID: 8304046
[TBL] [Abstract][Full Text] [Related]
7. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3.
Evans DB; Thavarajah M; Binderup L; Kanis JA
J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
11. Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro.
Kassem M; Mosekilde L; Eriksen EF
Biochem Mol Biol Int; 1993 Jul; 30(4):779-88. PubMed ID: 8401333
[TBL] [Abstract][Full Text] [Related]
12. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
[TBL] [Abstract][Full Text] [Related]
13. [Interaction effects between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta1 on the proliferation and differentiation of human embryonic osteoblasts].
Pei Y; Zhou XY; Meng XW; Xia WB; Xing XP; Liu HC; Hu YY
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1084-8. PubMed ID: 12899784
[TBL] [Abstract][Full Text] [Related]
14. Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol.
Atmani H; Chappard D; Basle MF
J Cell Biochem; 2003 May; 89(2):364-72. PubMed ID: 12704799
[TBL] [Abstract][Full Text] [Related]
15. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
16. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
de Pollak C; Arnaud E; Renier D; Marie PJ
J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761
[TBL] [Abstract][Full Text] [Related]
17. Integrin beta1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D3.
Wang L; Zhao G; Olivares-Navarrete R; Bell BF; Wieland M; Cochran DL; Schwartz Z; Boyan BD
Biomaterials; 2006 Jul; 27(20):3716-25. PubMed ID: 16569430
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells.
Moreau R; Aubin R; Lapointe JY; Lajeunesse D
J Bone Miner Res; 1997 Dec; 12(12):1984-92. PubMed ID: 9421231
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
Marie PJ; De Vernejoul MC; Lomri A
J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
[TBL] [Abstract][Full Text] [Related]
20. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
